Early automated insulin delivery for new type 1 diabetes patients
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests an automated insulin delivery system within 2 weeks of a type 1 diabetes diagnosis to see if it helps manage blood sugar early on. It is for patients who will get their diabetes care at Stanford Children's Hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with type 1 diabetes in the last 2 weeks
- You plan to get your diabetes care at Stanford Children's Pediatric Diabetes Clinic
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether starting automated insulin delivery (a system that adjusts insulin automatically) early after diagnosis helps children and teens with type 1 diabetes manage their blood sugar better. It also looks at long-term health and costs.
This trial tests whether an automated insulin delivery system (artificial pancreas) can help people recently diagnosed with type 1 diabetes manage their blood sugar better. The goal is to see if early use of this technology can preserve the body's ability to make some insulin.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests a new hybrid closed-loop system (an automated insulin pump) in people with type 1 diabetes whose blood sugar is not well controlled. It aims to see if the system is safe and helps improve glucose levels.
This study compares a new automated insulin delivery algorithm (AIDANET) in two modes: fully closed-loop (no user input needed) versus hybrid closed-loop (user still gives some insulin for meals). It tests how well the algorithm works in real-life settings for adults with type 1 diabetes.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.